Assessing clinical outcomes of vancomycin treatment in adult patients with penicillin-resistant Enterococcus faecium bacteremia

Hiroshi Sasano, Ryutarou Arakawa, Kazuhiko Hanada
doi: https://doi.org/10.1101/2022.04.27.22274384

Article Information

doi 
https://doi.org/10.1101/2022.04.27.22274384
History 
  • April 28, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Hiroshi Sasano1,2,
  2. Ryutarou Arakawa2 and
  3. Kazuhiko Hanada1,*
  1. 1Department of Pharmacometrics and Pharmacokinetics, Meiji Pharmaceutical University, Tokyo, Japan
  2. 2Department of Pharmacy, Juntendo University Hospital, Tokyo, Japan
  1. ↵*Corresponding author E-mail: hanada{at}my-pharm.ac.jp (KH)
Back to top
Posted April 28, 2022.
Download PDF
Data/Code
Email
Assessing clinical outcomes of vancomycin treatment in adult patients with penicillin-resistant Enterococcus faecium bacteremia
Hiroshi Sasano, Ryutarou Arakawa, Kazuhiko Hanada
medRxiv 2022.04.27.22274384; doi: https://doi.org/10.1101/2022.04.27.22274384
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area